Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Duncan Haworth"'
Autor:
Anand S. Dutta, Amanda Rees, Alec Jamieson, Duncan Haworth, Rod S. Kittlety, Lorraine A. Hassall, Paul Gellert, James J. Gormley, Christopher F. Reilly, Peter J. Alcock, Christopher F. Hayward, Linda J. Wood, Mandy L. Crowther, Julie M. Moores
Publikováno v:
Journal of Peptide Science. 6:321-341
Potent monomeric and dimeric cyclic peptide very late antigen-4 (VLA-4) inhibitors have been designed based on a tetrapeptide (Ile-Leu-Asp-Val) sequence present in a 25-amino acid peptide (CS-1) reported in the literature. The peptides, synthesized b
Autor:
Paul Gellert, Peter J. Alcock, Duncan Haworth, Anand S. Dutta, Tracy Halterman, Roger Ferguson, Linda J. Wood, Julie M. Moores, Lorraine A. Hassall, Christopher F. Hayward, James J. Gormley, Christopher F. Reilly, Matthew M Coath, Jackie Moors, Amanda Rees, Rod S. Kittlety, Alec Jamieson
Publikováno v:
Journal of Peptide Science. 6:398-412
Additional structure–activity relationship studies on potent cyclic peptide inhibitors of very late antigen-4 (VLA-4) are reported. The new N- to C-terminal cyclic hexa-, hepta- and octapeptide inhibitors like cyclo(MeIle/MePhe-Leu-Asp-Val-X) (X=2
Autor:
Peter J. Alcock, Amanda Rees, Anand S. Dutta, Alec Jamieson, Christopher F. Reilly, Duncan Haworth, Huw B Jones, Linda J. Wood, James J. Gormley
Publikováno v:
British Journal of Pharmacology. 126:1751-1760
1. Small, N- to C-terminal cyclized peptides containing the leucyl-aspartyl-valine (LDV) motif from fibronectin connecting segment-1 (CS-1) have been investigated for their effects on the adhesion of human T-lymphoblastic leukaemia cells (MOLT-4) to
Autor:
Frank Carey, Duncan Haworth
Publikováno v:
Prostaglandins. 31:33-45
It has been proposed that thromboxane synthase inhibition (TXSI) may be a useful form of anti-thrombotic therapy and that this is due, in part, to redirection of PGH2 metabolism in favour of PGI2, a potent vasodilator and anti-platelet agent. While r
Publikováno v:
Prostaglandins, Leukotrienes and Essential Fatty Acids. 36:57-61
In clinical and pre-clinical research the pharmacodynamics of selective 5-lipoxygenase and dual 5-lipoxygenase/cyclo-oxygenase inhibitors may be studied by direct RIA of plasma LTB4. Although immunoreactive LTB4 in plasma from A23187 stimulated human
Publikováno v:
Cardiovascular Research. 17:127-131
The plasma concentrations of immunoreactive thromboxane B2 and 6-keto-prostaglandin-F1 alpha were determined in coronary venous blood sampled from open-chested, anaesthetised beagle dogs by local vein catheterisation. Thromboxane levels were high imm
Publikováno v:
Biochemical Society Transactions. 16:818-820
Autor:
Duncan Haworth, Frank Carey
Publikováno v:
Prostaglandins. 31(1)
In the preceding paper we described the characterisation of an acute intravenous challenge model for the evaluation of the effects of thromboxane synthase inhibition (TXSI) on eicosanoid metabolism. Herein we describe the biochemical pharmacology of
Publikováno v:
Bioanalysis of Drugs and Metabolites, Especially Anti-Inflammatory and Cardiovascular ISBN: 9781475794267
Membrane-bound avachidonic acid is a precursor for PG and LT biosynthesis*. Members of this family of autocoids have been implicated in pathophysiology including regulation of microvascular blood flow and permeability, leukocyte chemotaxis, hyperalge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65de0c7d78ad91ea8ad18293e8ef101e
https://doi.org/10.1007/978-1-4757-9424-3_6
https://doi.org/10.1007/978-1-4757-9424-3_6
Publikováno v:
Clinical science (London, England : 1979). 67(6)
1. Levels of immunoreactive 6-oxo-prostaglandin F1α (6-oxo-PGF1α) and thromboxane B2 (TXB2) were measured in peripheral venous plasma in a group of volunteers and non-insulin dependent diabetic patients (NIDDS). Levels of these eicosanoids were clo